Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett's associated esophageal adenocarcinoma Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Barrett Esophagus
  • Esophageal Neoplasms
  • Esophagus

abstract

  • Current surveillance methods in Barrett's esophagus are invasive and neither cost-effective nor sensitive. This pilot study suggests that serum mesothelin is a marker of neoplastic transformation in BE and may provide a noninvasive method to improve identification of malignant transformation.

publication date

  • March 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3297720

Digital Object Identifier (DOI)

  • 10.1158/1055-9965.EPI-11-0993

PubMed ID

  • 22237988

Additional Document Info

start page

  • 482

end page

  • 6

volume

  • 21

number

  • 3